Boston closes $600 million public offering:
This article was originally published in Clinica
Executive Summary
Boston Scientific has completed a public debt offering worth $600m in senior notes. The Natick, Massachusetts company had originally planned to offer $500m but increased this amount to $600m, due, reportedly, to high demand for the 10-year notes. Boston says it plans to use the proceeds to repay commercial paper borrowings and for other general corporate purposes.